Ledger.Open graph →

SEC Form D · Amendment · filed November 3, 2011

NGM BIOPHARMACEUTICALS INC

Offering

$55.7M

Sold

$38.5M

Exemption

—

Industry

Biotechnology

Location

SOUTH SAN FRANCISCO, CA

Type

—

People & firms on this filing (16)

Michael Hormaechea · Boise, IDExec · Director Arthur D. Levinson · South San Francisco, CADirector Peter Svennilson · Gulf Stream, FLDirector Helen Kim · South San Francisco, CAExec Gail Naughton · Encinitas, CADirector James J. Lynch · HARTFORD, CTExec · Director Marc Leschly · Palo Alto, CADirector Steven J. Kapiloff · HARTFORD, CTExec · Director Monika Wingate · Madison, WIExec · Director Jane Boutelle · Madison, WIExec · Director Michael Phippen · Mill Valley, CAExec · Director Elliott Elbaz · Mill Valley, CADirector Robert Pinnick · Bend, ORExec Rajan Sobhani · Plano, TXDirector Ravi Mohan · Menlo Park, CADirector Frank G. Mazzola · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗